Exelixis, Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved CABOMETYX® (cabozantinib) for the treatment of 1) adult and pediatric patients 12 years of age and older ...

The global CAR T-cell therapy market is projected to grow from USD 2.7 billion in 2025 to over USD 27.5 billion by 2033, reflecting a robust CAGR of 26.2%.

As with its predecessor, the new drug candidate, Jun13296, targets a different viral protein than Paxlovid does and works ...

The study in the European Respiratory Journal used advanced spatial mapping techniques to compare healthy lung tissues and ...

Diclofenac is a generic drug that comes in several forms: immediate-release (IR) oral tablet, which is released in your body right away delayed-release (DR) oral tablet, which is released once it ...

ANI Pharmaceuticals (ANIP) announced the launch of Nitazoxanide Tablets, 500 mg. ANI’s Nitazoxanide Tablets are the generic version of the ...

“CMS may consider future policy options for (anti-obesity medications) pending further review of both the potential benefits of these drugs including updated clinical indications, and relevant ...

Ludhiana: A local court sentenced a drug peddler to ten years of rigorous imprisonment for the possession of 6,000 intoxicating tablets. Special court judge Jaspinder Singh also imposed a fine of ...

Imagine taking a prescription drug for months — only to learn it increases your risk of stroke or heart failure. When a new drug receives regulatory approval, doctors and patients assume it is safe.

The race is on to make the first oral weight loss medicines, but smaller US pharmacies may have already got there – if they ...

Following recommendations by the World Health Organization (WHO), the United Nations Commission on Narcotic Drugs (CND ... as a pharmaceutical product in tablet form, has been detected in ...